Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on sleep in brain health

LIVE: Thursday 2nd May 2024, 18:00-19:30 (CEST)

Quality sleep is essential for health. But what happens to our brains when sleep patterns are disturbed? Join our experts to explore the interplay between sleep disruption and neurological diseases, and the questions that you need to be asking your patients to help you prevent the harmful effects of sleep deprivation.
ADVANCED SEARCH
Log in
Top
The Journal of Headache and Pain
Published in: The Journal of Headache and Pain 1/2018

Open Access 01-12-2018 | Review article

Myofascial trigger points in migraine and tension-type headache

Authors: Thien Phu Do, Gerda Ferja Heldarskard, Lærke Tørring Kolding, Jeppe Hvedstrup, Henrik Winther Schytz

Published in: The Journal of Headache and Pain | Issue 1/2018

Login to get access

Abstract

Background

A myofascial trigger point is defined as a hyperirritable spot in skeletal muscle that is associated with a hypersensitive palpable nodule in a taut band. It has been suggested that myofascial trigger points take part in chronic pain conditions including primary headache disorders. The aim of this narrative review is to present an overview of the current imaging modalities used for the detection of myofascial trigger points and to review studies of myofascial trigger points in migraine and tension-type headache.

Findings

Different modalities have been used to assess myofascial trigger points including ultrasound, microdialysis, electromyography, infrared thermography, and magnetic resonance imaging. Ultrasound is the most promising of these modalities and may be used to identify MTrPs if specific methods are used, but there is no precise description of a gold standard using these techniques, and they have yet to be evaluated in headache patients.
Active myofascial trigger points are prevalent in migraine patients. Manual palpation can trigger migraine attacks. All intervention studies aiming at trigger points are positive, but this needs to be further verified in placebo-controlled environments. These findings may imply a causal bottom-up association, but studies of migraine patients with comorbid fibromyalgia syndrome suggest otherwise. Whether myofascial trigger points contribute to an increased migraine burden in terms of frequency and intensity is unclear.
Active myofascial trigger points are prevalent in tension-type headache coherent with the hypothesis that peripheral mechanisms are involved in the pathophysiology of this headache disorder. Active myofascial trigger points in pericranial muscles in tension-type headache patients are correlated with generalized lower pain pressure thresholds indicating they may contribute to a central sensitization. However, the number of active myofascial trigger points is higher in adults compared with adolescents regardless of no significant association with headache parameters. This suggests myofascial trigger points are accumulated over time as a consequence of TTH rather than contributing to the pathophysiology.

Conclusions

Myofascial trigger points are prevalent in both migraine and tension-type headache, but the role they play in the pathophysiology of each disorder and to which degree is unclarified. In the future, ultrasound elastography may be an acceptable diagnostic test.
Literature
1.
2.
Lyngberg AC, Rasmussen BK, Jørgensen T et al (2005) Secular changes in health care utilization and work absence for migraine and tension-type headache: a population based study. Eur J Epidemiol 20:1007–1014CrossRefPubMed
3.
Olesen J, Sobscki P, Truelsen T et al (2008) Cost of disorders of the brain in Denmark. Nord J Psychiatry 62:114–120CrossRefPubMed
4.
Olesen J, Burstein R, Ashina M et al (2009) Origin of pain in migraine: evidence for peripheral sensitisation. Lancet Neurol 8:679–690CrossRefPubMed
5.
Noseda R, Burstein R (2013) Migraine pathophysiology: anatomy of the trigeminovascular pathway and associated neurological symptoms, CSD, sensitization and modulation of pain. Pain 154:44–53CrossRef
6.
Shevel E (2011) The extracranial vascular theory of migraine--a great story confirmed by the facts. Headache 51:409–417CrossRefPubMed
7.
Goadsby PJ (2009) The vascular theory of migraine--a great story wrecked by the facts. Brain 132:6–7CrossRefPubMed
8.
Asghar MS, Hansen AE, Amin FM et al (2011) Evidence for a vascular factor in migraine. Ann Neurol 69:635–645CrossRefPubMed
9.
Amin FM, Asghar MS, Hougaard A et al (2013) Magnetic resonance angiography of intracranial and extracranial arteries in patients with spontaneous migraine without aura: a cross-sectional study. Lancet Neurol 12:454–461CrossRefPubMed
10.
Hay KM (1979) Pain thresholds in migraine. Practitioner 222:827–833PubMed
11.
Olesen J (1978) Some clinical features of the acute migraine attack. An analysis of 750 patients. Headache 18:268–271CrossRefPubMed
12.
Olesen J (1991) Clinical and pathophysiological observations in migraine and tension-type headache explained by integration of vascular, supraspinal and myofascial inputs. Pain 46:125–132CrossRefPubMed
13.
GBD 2015 Neurological Disorders Collaborator Group (2017) Global, regional, and national burden of neurological disorders during 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet Neurol 16:877–897CrossRef
14.
Lipchik GL, Holroyd KA, O’Donnell FJ et al (2000) Exteroceptive suppression periods and pericranial muscle tenderness in chronic tension-type headache: effects of psychopathology, chronicity and disability. Cephalalgia 20:638–646CrossRefPubMed
15.
Buchgreitz L, Lyngberg AC, Bendtsen L et al (2006) Frequency of headache is related to sensitization: a population study. Pain 123:19–27CrossRefPubMed
16.
Fernández-de-Las-Peñas C, Cuadrado ML, Arendt-Nielsen L et al (2007) Increased pericranial tenderness, decreased pressure pain threshold, and headache clinical parameters in chronic tension-type headache patients. Clin J Pain 23:346–352CrossRefPubMed
17.
Sakai F, Ebihara S, Akiyama M et al (1995) Pericranial muscle hardness in tension-type headache. A non-invasive measurement method and its clinical application. Brain 118(Pt 2):523–531CrossRefPubMed
18.
Ashina M, Bendtsen L, Jensen R et al (1999) Muscle hardness in patients with chronic tension-type headache: relation to actual headache state. Pain 79:201–205CrossRefPubMed
19.
Simons D, Travell J (1999) Travell & Simons’ myofascial pain and dysfunction: the trigger point manual. Williams & Wilkins, Baltimore
20.
Travell J, Simons D (1952) The myofascial genesis of pain. Postgrad Med 11:434–452CrossRef
21.
Stockman R (1904) The causes, pathology and treatment of chronic rheumatism. Edinburgh Med J 15:107–116
22.
Shah JP, Thaker N, Heimur J et al (2015) Myofascial trigger point then and now: a historical and scientific prespective. PM R J 7:746–761CrossRef
23.
Wolfe F, Simons D, Fricton J et al (1992) The fibromyalgia and myofascial pain syndromes: a preliminary study of tender points and trigger points in persons with fibromyalgia, myofascial pain syndrome and no disease. J Rheumatol 19:944–951PubMed
24.
25.
Shah JP, Danoff JV, Desai MJ et al (2008) Biochemicals associated with pain and inflammation are elevated in sites near to and remote from active myofascial trigger points. Arch Phys Med Rehabil 89:16–23CrossRefPubMed
26.
Shah JP, Phillips TM, Danoff JV et al (2005) An in vivo microanalytical technique for measuring the local biochemical milieu of human skeletal muscle. J Appl Physiol 99:1977–1984CrossRefPubMed
27.
Sikdar S, Shah JP, Gebreab T et al (2009) Novel applications of ultrasound technology to visualize and characterize myofascial trigger points and surrounding soft tissue. Arch Phys Med Rehabil 90:1829–1838CrossRefPubMedPubMedCentral
28.
Lewis J, Tehan P (1999) A blinded pilot study investigating the use of diagnostic ultrasound for detecting active myofascial trigger points. Pain 79:39–44CrossRefPubMed
29.
Turo D, Otto P, Shah JP et al (2012) Ultrasonic tissue characterization of the upper trapezius muscle in patients with myofascial pain syndrome. Conf Proc IEEE Eng Med Biol Soc 2012:4386–4389PubMedPubMedCentral
30.
Sikdar S, Shah JP, Gilliams E et al (2008) Assessment of myofascial trigger points (MTrPs): a new application of ultrasound imaging and vibration sonoelastography. Conf Proc IEEE Eng Med Biol Soc 2008:5585–5588PubMed
31.
Ballyns JJ, Shah JP, Hammond J et al (2011) Objective sonographic measures for characterizing myofascial trigger points associated with cervical pain. J Ultrasound Med 30:1331–1340CrossRefPubMedPubMedCentral
32.
Takla MKN, Razek NMA, Kattabei O et al (2016) A comparison between different modes of real-time sonoelastography in visualizing myofascial trigger points in low back muscles. J Man Manip Ther 24:253–263CrossRefPubMedPubMedCentral
33.
Simons DG, Hong C-Z, Simons LS (2002) Endplate potentials are common to midfiber myofacial trigger points. Am J Phys Med Rehabil 81:212–222CrossRefPubMed
34.
Ge HY, Monterde S, Graven-Nielsen T et al (2014) Latent myofascial trigger points are associated with an increased intramuscular electromyographic activity during synergistic muscle activation. J Pain 15:181–187CrossRefPubMed
35.
36.
Wytrążek M, Huber J, Lipiec J et al (2015) Evaluation of palpation, pressure algometry, and electromyography for monitoring trigger points in young participants. J Manip Physiol Ther 38:232–243CrossRef
37.
Dibai-Filho AV, Guirro RR (2015) Evaluation of myofascial trigger points using infrared thermography: a critical review of the literature. J Manip Physiol Ther 38:86–92CrossRef
38.
Merla A, Ciuffolo F, D’Attilio M et al (2004) Functional infrared imaging in the diagnosis of the myofascial pain. Conf Proc IEEE Eng Med Biol Soc 2:1188–1191PubMed
39.
Kimura Y, Ge H-Y, Zhang Y et al (2009) Evaluation of sympathetic vasoconstrictor response following nociceptive stimulation of latent myofascial trigger points in humans. Acta Physiol (Oxf) 196:411–417CrossRef
40.
Zhang Y, Ge H-Y, Yue S-W et al (2009) Attenuated skin blood flow response to nociceptive stimulation of latent myofascial trigger points. Arch Phys Med Rehabil 90:325–332CrossRefPubMed
41.
Haddad DS, Brioschi ML, Arita ES (2012) Thermographic and clinical correlation of myofascial trigger points in the masticatory muscles. Dentomaxillofac Radiol 41:621–629CrossRefPubMedPubMedCentral
42.
Chen Q, Wang H, Gay RE et al (2016) Quantification of myofascial taut bands. Arch Phys Med Rehabil 97:67–73CrossRefPubMed
43.
Eller-Smith OC, Nicol AL, Christianson JA (2018) Potential mechanisms underlying centralized pain and emerging therapeutic interventions. Front Cell Neurosci 12:35CrossRefPubMedPubMedCentral
44.
Tfelt-Hansen P, Lous I, Olesen J (1981) Prevalence and significance of muscle tenderness during common migraine attacks. Headache 21:49–54CrossRefPubMed
45.
Calandre EP, Hidalgo J, García-Leiva JM et al (2006) Trigger point evaluation in migraine patients: an indication of peripheral sensitization linked to migraine predisposition? Eur J Neurol 13:244–249CrossRefPubMed
46.
Fernández-de-Las-Peñas C, Cuadrado ML, Pareja JA (2006) Myofascial trigger points, neck mobility and forward head posture in unilateral migraine. Cephalalgia 26:1061–1070CrossRefPubMed
47.
Ferracini GN, Florencio LL, Dach F et al (2017) Myofascial trigger points and migraine-related disability in women with episodic and chronic migraine. Clin J Pain 33:109–115CrossRefPubMed
48.
Ferracini GN, Chaves TC, Dach F et al (2016) Relationship between active trigger points and head/neck posture in patients with migraine. Am J Phys Med Rehabil. 95:831–839CrossRefPubMed
49.
Florencio LL, Ferracini GN, Chaves TC et al (2017) Active trigger points in the cervical musculature determine the altered activation of superficial neck and extensor muscles in women with migraine. Clin J Pain 33:238–245PubMed
50.
Gandolfi M, Geroin C, Valè N et al Does myofascial and trigger point treatment reduce pain and analgesic intake in patients undergoing OnabotulinumtoxinA injection due to chronic intractable migraine? A pilot, single-blind randomized controlled trial. Eur J Phys Rehabil Med. Epub ahead of print 27 July 2017. https://​doi.​org/​10.​23736/​S1973-9087.​17.​04568-3
51.
Ghanbari A, Askarzadeh S, Petramfar P et al (2015) Migraine responds better to a combination of medical therapy and trigger point management than routine medical therapy alone. NeuroRehabilitation 37:157–163CrossRefPubMed
52.
Giamberardino MA, Tafuri E, Savini A et al (2007) Contribution of myofascial trigger points to migraine symptoms. J Pain 8:869–878CrossRefPubMed
53.
Landgraf MN, Biebl JT, Langhagen T et al Children with migraine: provocation of headache via pressure to myofascial trigger points in the trapezius muscle? - a prospective controlled observational study. Eur J Pain. Epub ahead of print 26 September 2017. https://​doi.​org/​10.​1002/​ejp.​1127
54.
Landgraf MN, Ertl-Wagner B, Koerte IK et al (2015) Alterations in the trapezius muscle in young patients with migraine--a pilot case series with MRI. Eur J Paediatr Neurol 19:372–376CrossRefPubMed
55.
Palacios-Ceña M, Ferracini GN, Florencio LL et al (2017) The number of active but not latent trigger points associated with widespread pressure pain hypersensitivity in women with episodic migraines. Pain Med 18:2485–2491CrossRefPubMed
56.
Ranoux D, Martiné G, Espagne-Dubreuilh G et al (2017) OnabotulinumtoxinA injections in chronic migraine, targeted to sites of pericranial myofascial pain: an observational, open label, real-life cohort study. J Headache Pain. 18:75CrossRefPubMedPubMedCentral
57.
Sollmann N, Trepte-Freisleder F, Albers L et al (2016) Magnetic stimulation of the upper trapezius muscles in patients with migraine - a pilot study. Eur J Paediatr Neurol 20:888–897CrossRefPubMed
58.
Tali D, Menahem I, Vered E et al (2014) Upper cervical mobility, posture and myofascial trigger points in subjects with episodic migraine: case-control study. J Bodyw Mov Ther 18:569–575CrossRefPubMed
59.
Affaitati G, Martelletti P, Lopopolo M et al (2017) Use of nonsteroidal anti-inflammatory drugs for symptomatic treatment of episodic headache. Pain Pract 17:392–401CrossRefPubMed
60.
Jensen RH (2017) Tension-type headache - the normal and most prevalent headache. Headache:1–7
61.
Kolding LT, Do TP, Ewertsen C et al (2018) Muscle stiffness in tension-type headache patients with pericranial tenderness. Cephalalgia Reports 1:251581631876029CrossRef
62.
Alonso-Blanco C, Fernández-de-las-Peñas C, Fernández-Mayoralas DM et al (2011) Prevalence and anatomical localization of muscle referred pain from active trigger points in head and neck musculature in adults and children with chronic tension-type headache. Pain Med 12:1453–1463CrossRefPubMed
63.
Fernández-de-las-Peñas C, Fernández-Mayoralas DM, Ortega-Santiago R et al (2011) Referred pain from myofascial trigger points in head and neck-shoulder muscles reproduces head pain features in children with chronic tension type headache. J Headache Pain. 12:35–43CrossRefPubMedPubMedCentral
64.
Fernández-de-las-Peñas C, Cuadrado ML, Gerwin RD et al (2005) Referred pain from the trochlear region in tension-type headache: a myofascial trigger point from the superior oblique muscle. Headache 45:731–737CrossRefPubMed
65.
Fernández-de-las-Peñas C, Alonso-Blanco C, Cuadrado ML et al (2006) Trigger points in the suboccipital muscles and forward head posture in tension-type headache. Headache 46:454–460CrossRefPubMed
66.
Fernández-de-Las-Peñas C, Ge H-Y, Arendt-Nielsen L et al (2007) The local and referred pain from myofascial trigger points in the temporalis muscle contributes to pain profile in chronic tension-type headache. Clin J Pain 23:786–792CrossRefPubMed
67.
Couppé C, Torelli P, Fuglsang-Frederiksen A et al (2007) Myofascial trigger points are very prevalent in patients with chronic tension-type headache: a double-blinded controlled study. Clin J Pain 23:23–27CrossRefPubMed
68.
Fernández-de-las-Peñas C, Caminero AB, Madeleine P et al (2009) Multiple active myofascial trigger points and pressure pain sensitivity maps in the temporalis muscle are related in women with chronic tension type headache. Clin J Pain 25:506–512CrossRefPubMed
69.
Fernández-de-Las-Peñas C, Cuadrado ML, Pareja JA (2007) Myofascial trigger points, neck mobility, and forward head posture in episodic tension-type headache. Headache 47:662–672CrossRefPubMed
70.
Fernández-de-Las-Peñas C, Ge H-Y, Arendt-Nielsen L et al (2007) Referred pain from trapezius muscle trigger points shares similar characteristics with chronic tension type headache. Eur J Pain 11:475–482CrossRefPubMed
71.
Fernández-de-Las-Peñas C, Alonso-Blanco C, Cuadrado ML et al (2006) Myofascial trigger points in the suboccipital muscles in episodic tension-type headache. Man Ther 11:225–230CrossRefPubMed
72.
Fernández-de-Las-Peñas C, Alonso-Blanco C, Cuadrado ML et al (2006) Myofascial trigger points and their relationship to headache clinical parameters in chronic tension-type headache. Headache 46:1264–1272CrossRefPubMed
73.
Harden RN, Cottrill J, Gagnon CM et al (2009) Botulinum toxin a in the treatment of chronic tension-type headache with cervical myofascial trigger points: a randomized, double-blind, placebo-controlled pilot study. Headache 49:732–743CrossRefPubMed
74.
Karadaş Ö, Inan LE, Ulaş ÜH et al (2013) Efficacy of local lidocaine application on anxiety and depression and its curative effect on patients with chronic tension-type headache. Eur Neurol 70:95–101CrossRefPubMed
75.
Lattes K, Venegas P, Lagos N et al (2009) Local infiltration of gonyautoxin is safe and effective in treatment of chronic tension-type headache. Neurol Res 31:228–233CrossRefPubMed
76.
Moraska AF, Schmiege SJ, Mann JD et al (2017) Responsiveness of myofascial trigger points to single and multiple trigger point release massages: a randomized, placebo controlled trial. Am J Phys Med Rehabil. 96:639–645CrossRefPubMedPubMedCentral
77.
Moraska AF, Stenerson L, Butryn N et al (2015) Myofascial trigger point-focused head and neck massage for recurrent tension-type headache: a randomized, placebo-controlled clinical trial. Clin J Pain 31:159–168CrossRefPubMedPubMedCentral
78.
79.
Romero-Morales C, Jaén-Crespo G, Rodríguez-Sanz D et al (2017) Comparison of pressure pain thresholds in upper trapezius and temporalis muscles trigger points between tension type headache and healthy participants: a case-control study. J Manip Physiol Ther 40:609–614CrossRef
80.
Sohn J, Choi H, Lee S-M et al (2010) Differences in cervical musculoskeletal impairment between episodic and chronic tension-type headache. Cephalalgia 30:1514–1523CrossRefPubMed
81.
Karadaş Ö, Gül HL, Inan LE (2013) Lidocaine injection of pericranial myofascial trigger points in the treatment of frequent episodic tension-type headache. J Headache Pain 14:44CrossRefPubMedPubMedCentral
82.
Schytz HW, Amin FM, Selb J et al (2017) Non-invasive methods for measuring vascular changes in neurovascular headaches. J Cereb Blood Flow Metab 271678X17724138
83.
Ashina M, Stallknecht B, Bendtsen L et al (2003) Tender points are not sites of ongoing inflammation - In vivo evidence in patients with chronic tension-type headache. Cephalalgia 23:109–116CrossRefPubMed
84.
Giamberardino MA, Affaitati G, Martelletti P et al (2015) Impact of migraine on fibromyalgia symptoms. J Headache Pain. 17:28CrossRefPubMed
85.
Wolfe F, Smythe HA, Yunus MB et al (1990) The American College of Rheumatology 1990 criteria for the classification of fibromyalgia. Report of the multicenter criteria committee. Arthritis Rheum 33:160–172CrossRefPubMed
86.
Ifergane G, Buskila D, Simiseshvely N et al (2006) Prevalence of fibromyalgia syndrome in migraine patients. Cephalalgia 26:451–456CrossRefPubMed
87.
Jackson JL, Kuriyama A, Hayashino Y (2012) Botulinum toxin a for prophylactic treatment of migraine and tension headaches in adults: a meta-analysis. JAMA 307:1736–1745CrossRefPubMed
88.
Do TP, Hvedstrup J, Schytz HW (2018) Botulinum toxin: a review of the mode of action in migraine. Acta Neurol Scand 137:442–451CrossRefPubMed
89.
Gerwin RD, Shannon S, Hong CZ et al (1997) Interrater reliability in myofascial trigger point examination. Pain 69:65–73CrossRefPubMed
Metadata
Title
Myofascial trigger points in migraine and tension-type headache
Authors
Thien Phu Do
Gerda Ferja Heldarskard
Lærke Tørring Kolding
Jeppe Hvedstrup
Henrik Winther Schytz
Publication date
01-12-2018
Publisher
Springer Milan
Published in
The Journal of Headache and Pain / Issue 1/2018
Print ISSN: 1129-2369
Electronic ISSN: 1129-2377
DOI
https://doi.org/10.1186/s10194-018-0913-8

Other articles of this Issue 1/2018

The Journal of Headache and Pain 1/2018 Go to the issue

Research article

Association of migraines with brain tumors: a nationwide population-based study

Research article

Intracortical facilitation within the migraine motor cortex depends on the stimulation intensity. A paired-pulse TMS study

Review article

Discovery of PACAP and its receptors in the brain

Review article

PACAP in hypothalamic regulation of sleep and circadian rhythm: importance for headache

Review article

PACAP38 and PAC1 receptor blockade: a new target for headache?

Research article

Implications for the migraine SNP rs1835740 in a Swedish cluster headache population